Endothelin-converting enzyme inhibitors

Cristina Navarrete, Cleide Suguihara

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Endothelin-1 (ET-1) is a peptide with various biological activities, such as vasoconstriction, mitogenesis and bronchoconstriction. It has been implicated in the pathogenesis of numerous disease processes. Suppression of the production of this peptide by inhibitors of endothelin-converting enzyme-1 (ECE-1), the key enzyme in ET-1 biosynthesis, may be a therapeutic option. There are three classes of ECE-1 inhibitors: selective ECE-1 inhibitors, dual ECE-1/neutral endopeptidase (NEP) 24.11 inhibitors and triple ECE-1/NEP/ angiotensin-converting enzyme inhibitors. This review will focus briefly on the endothelin system and mainly on the ECE-1 inhibitor classes, their pharmacologic effects on animal models of various diseases and published clinical studies.

Original languageEnglish (US)
Pages (from-to)373-378
Number of pages6
JournalCurrent Enzyme Inhibition
Issue number4
StatePublished - Nov 1 2006


  • ECE-1 inhibitors
  • Endothelin-1
  • Endothelin-converting enzyme

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Endothelin-converting enzyme inhibitors'. Together they form a unique fingerprint.

Cite this